The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment patterns and site of metastasis in patients with metastatic colorectal cancer (mCRC).
Sheikh Usman Iqbal
Employment or Leadership Position - Sanofi
Stephen F Thompson
Employment or Leadership Position - Sanofi
Sarah Naoshy
Consultant or Advisory Role - Sanofi
Daniel B Ng
Employment or Leadership Position - Sanofi
Michael Wooten
Employment or Leadership Position - Regeneron
Stock Ownership - Regeneron
Steven A Sherman
Consultant or Advisory Role - Analytica LA-SER International
Elisabetta Malangone
Employment or Leadership Position - Analytica LA-SER International
Consultant or Advisory Role - Analytica LA-SER International
Research Funding - Sanofi
Lee Stern
Research Funding - Analytica LA-SER International
Magdaliz Gorritz-Kindu
Consultant or Advisory Role - Sanofi/Regeneron